AKT1 and cancer: Similarly, miR‐29b can also suppress the progress of glycolysis by inhibiting the signalling of both PKM2 and AKT‐HK2 in cells of ovarian cancer, suggesting a critical role of miR‐29b in controlling the metabolism of glucose in cancer cells.23